| IPI00734784 - Tp53, CELLULAR TUMOR ANTIGEN P53. | |
|---|---|
| Uniprot Accession: P10361 | |
| Uniprot ID: P53_RAT | |
| Mapping: Chr 10, 56399668 - 56411149 | |
| Entrez Gene: 24842 | |
| Entrez MapView: |
|
| RGD: 3889 | |
| +All IPI Database Cross References | |
| IPI records in this ortholog cluster (Cluster: MGI_ORTHOLOGY_9697) |
|---|
| Rat: Tp53, CELLULAR TUMOR ANTIGEN P53. |
| Mouse: Trp53, CELLULAR TUMOR ANTIGEN P53. |
| Mouse: Trp53, CELLULAR TUMOR ANTIGEN P53. |
| Rat: Tp53, CELLULAR TUMOR ANTIGEN P53. |
| Rat: Tp53, MUTANT P53. |
| Rat: Tp53, CELLULAR TUMOR ANTIGEN P53. |
| Human: TP53, ISOFORM 1 OF CELLULAR TUMOR ANTIGEN P53. |
| Human: TP53, ISOFORM 2 OF CELLULAR TUMOR ANTIGEN P53. |
| Human: TP53, CELLULAR TUMOR ANTIGEN P53. |
| Human: TP53, CELLULAR TUMOR ANTIGEN P53 (FRAGMENT). |
| Human: TP53, CELLULAR TUMOR ANTIGEN P53 (FRAGMENT). |
| Human: TP53, P53-EX10 ISOFORM (FRAGMENT). |
| GO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| replication fork | C | IDA | ISS | |
| cytoplasm | C | IDA IDA IDA ISS | ISS ISS IMP ISS | |
| endoplasmic reticulum | C | IEA | IEA | |
| mitochondrion | C | ISS ISS | ||
| nucleolus | C | ISS ISS | ||
| nucleoplasm | C | ISS | ||
| nuclear matrix | C | ISS | ||
| cytosol | C | IDA | ISS | |
| nucleus | C | IEA | IDA IDA IDA ISS IDA | ISS ISS IMP IEA ISS |
| insoluble fraction | C | ISS | ||
| enzyme binding | F | ISS | ||
| protein N-terminus binding | F | ISS | ||
| ATP binding | F | ISS ISS | ||
| transcription factor activity | F | IEA | IDA IDA IDA | ISS ISS IEA |
| RNA polymerase II transcription factor activity | F | TAS | ||
| chromatin binding | F | ISS | ||
| nuclease activity | F | ISS | ||
| protein binding | F | IPI | IPI IPI IPI IPI IPI IPI IPI IPI IPI IPI | ISS ISS IPI |
| copper ion binding | F | ISS ISS | ||
| zinc ion binding | F | IEA | IEA | ISS IEA |
| DNA binding | F | IDA IDA IDA IDA | ISS | |
| metal ion binding | F | IEA | IEA | IEA |
| protein heterodimerization activity | F | ISS | ||
| DNA strand annealing activity | F | ISS ISS | ||
| cell cycle | P | IEA | IEA | IEA |
| central nervous system development | P | IGI | ||
| response to DNA damage stimulus | P | IDA IMP ISS IDA | ISS ISS | |
| cellular response to glucose starvation | P | ISS | ||
| cell aging | P | ISS ISS | ||
| cell proliferation | P | ISS | ||
| positive regulation of transcription | P | IDA IGI | ISS | |
| induction of apoptosis | P | IDA IMP | ISS | |
| negative regulation of apoptosis | P | IMP | ISS | |
| multicellular organismal development | P | ISS | ||
| regulation of mitochondrial membrane permeability | P | ISS | ||
| regulation of progression through cell cycle | P | IMP | ISS | |
| base-excision repair | P | ISS | ||
| cell differentiation | P | ISS | ||
| response to gamma radiation | P | IDA | ||
| embryonic development ending in birth or egg hatching | P | IGI | ISS | |
| negative regulation of neuroblast proliferation | P | IGI | ||
| negative regulation of cell growth | P | TAS ISS ISS | ||
| response to UV | P | IMP IDA | ISS | |
| in utero embryonic development | P | IGI IGI | ||
| negative regulation of cell proliferation | P | IGI IGI IGI IGI | ||
| positive regulation of transcription from RNA polymerase II promoter | P | IDA IDA ISS | ISS | |
| cell cycle arrest | P | ISS | ||
| G1 DNA damage checkpoint | P | IMP | ISS | |
| regulation of cell proliferation | P | IMP | ISS | |
| caspase activation via cytochrome c | P | ISS ISS | ||
| transcription | P | IEA | IEA | |
| apoptosis | P | IEA | IGI IDA | ISS ISS IEA ISS |
| nucleotide-excision repair | P | ISS ISS | ||
| positive regulation of neuron apoptosis | P | IMP IDA IMP IGI | ||
| DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis | P | IMP ISS ISS IGI | ISS ISS | |
| regulation of transcription, DNA-dependent | P | IEA | IDA | ISS ISS |
| regulation of apoptosis | P | ISS | ||
| protein tetramerization | P | ISS | ||
| response to X-ray | P | IDA | ISS | |
| protein import into nucleus, translocation | P | IDA | ISS | |
| negative regulation of progression through cell cycle | P | IEA | IEA | IEA |
| positive regulation of transcription, DNA-dependent | P | IDA | ||
| positive regulation of apoptosis | P | IMP | ||
| ER overload response | P | ISS | ||
| regulation of neuron apoptosis | P | IGI | ||
| protein complex assembly | P | ISS | ||
| regulation of cellular pH | P | IMP | ||
| release of cytochrome c from mitochondria | P | IDA | ||
| negative regulation of fibroblast proliferation | P | IMP | ISS | |
| negative regulation of DNA replication | P | IDA IMP | ISS | |
| negative regulation of helicase activity | P | ISS | ||
| DNA damage response, signal transduction by p53 class mediator | P | IGI IGI IDA IDA | ISS | |
| regulation of transcription from RNA polymerase II promoter | P | TAS |
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| GO Graph Color Key: | Rat | Mouse | Human | Rat & Mouse | Mouse & Human | Rat & Human | Rat, Mouse & Human |
SVG image
| MP Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| craniofacial phenotype | MP | Un | ||
| skin/coat/nails phenotype | MP | Un Un Un Un Un Un Un | ||
| cellular phenotype | MP | Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un | ||
| homeostasis/metabolism phenotype | MP | Un | ||
| behavior/neurological phenotype | MP | Un | ||
| endocrine/exocrine gland phenotype | MP | Un Un Un | ||
| immune system phenotype | MP | Un Un Un | ||
| embryogenesis phenotype | MP | Un Un Un Un Un | ||
| lethality-embryonic/perinatal | MP | Un Un Un Un Un Un Un Un Un Un Un Un Un | ||
| muscle phenotype | MP | Un | ||
| skeleton phenotype | MP | Un Un Un Un | ||
| lethality-postnatal | MP | Un | ||
| renal/urinary system phenotype | MP | Un | ||
| growth/size phenotype | MP | Un Un Un Un Un | ||
| respiratory system phenotype | MP | Un Un | ||
| vision/eye phenotype | MP | Un Un | ||
| tumorigenesis | MP | Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un Un | ||
| digestive/alimentary phenotype | MP | Un | ||
| normal phenotype | MP | Un Un Un | ||
| cardiovascular system phenotype | MP | Un Un Un Un | ||
| life span-post-weaning/aging | MP | Un Un Un Un Un Un Un Un Un Un Un Un | ||
| hematopoietic system phenotype | MP | Un Un | ||
| reproductive system phenotype | MP | Un Un Un | ||
| no phenotypic analysis | MP | Un | ||
| nervous system phenotype | MP | Un Un Un | ||
| abnormal apoptosis | N | ISS | ||
| increased tumor incidence | N | ISS |
| DO Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Coronary Restenosis | D | ISS |
| PW Term | Aspect | Human | Mouse | Rat |
|---|---|---|---|---|
| Wnt signaling pathway | W | IEA | ||
| programmed cell death pathway | W | IEA | ||
| amyotrophic lateral sclerosis disease pathway | W | IEA | ||
| p53-dependent G1/S DNA damage checkpoint pathway | W | IEA | ||
| mitogen activated protein kinase signaling pathway | W | IEA | ||
| Huntington disease pathway | W | IEA |
| KEGG Pathway | Human | Mouse | Rat |
|---|---|---|---|
| Glioma (05214) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Chronic myeloid leukemia (05220) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Cell cycle (04110) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Apoptosis (04210) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| MAPK signaling pathway (04010) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Amyotrophic lateral sclerosis (ALS) (05030) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Wnt signaling pathway (04310) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Colorectal cancer (05210) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Huntington's disease (05040) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |
| Pancreatic cancer (05212) | Present in KEGG pathway | Present in KEGG pathway | Present in KEGG pathway |